Gibson, Dunn & Crutcher LLP acted as outside counsel, and Goodwin Procter LLP, as special counsel, have advised Cogent Biosciences, Inc., while Mintz has advised the...
Cogent Biosciences Completes $230 Million Public Offering
Kymera Therapeutics Completes $288 Million Public Offering
Goodwin Procter has advised Kymera Therapeutics, Inc. on the offering, and WilmerHale has advised the underwriters. Kymera Therapeutics, Inc. has completed a public offering amounting to...
Trevi Therapeutics Issues $115 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr advised Trevi Therapeutics, Inc., and Covington & Burling advised the underwriters. Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company,...
BrightSpring Health Services Completes $304.5 Million Secondary Offering
Barnes & Thornburg LLP has advised BrightSpring Health Services. Latham & Watkins LLP has advised the underwriters. BrightSpring Health Services, Inc., a leading provider of home...
Insmed Completes $750 Million Follow-On Public Offering
Covington & Burling has advised Insmed Inc. on the offering, Hunton Andrew Kurth served as Virginia counsel and Cooley as intellectual property counsel to the company,...
Maze Therapeutics’ $140 Million Upsized Initial Public Offering
Fenwick & West represented Maze Therapeutics in the offering, and Davis Polk & Wardwell represented the underwriters. Maze Therapeutics, Inc. (Nasdaq: MAZE) announced its upsized initial...
Disc Medicine’s $259.3 Million Follow-on Offering
Goodwin Procter advised Disc Medicine, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the offering. Disc Medicine (NASDAQ: IRON) announced its upsized underwritten...
Trevi Therapeutics’ $50 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr represented Trevi Therapeutics, Inc. in the offering, and Covington & Burling represented the underwriters. Trevi Therapeutics, Inc. (Nasdaq: TRVI), a...
Ardent Health’s $192 Million IPO
Sidley Austin represented Ardent Health Partners, Inc. in the offering, and Latham & Walkins represented the underwriters. Ardent Health Partners, Inc. (f/k/a Ardent Health Partners, LLC...
Disc Medicine’s $178 Million Common Stock Offering
Goodwin Procter advised Disc Medicine, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriter. Disc Medicine, Inc. (Nasdaq: IRON) (“Disc”) announced...
Nkarta’s $240 Million Common Stock Offering
O’Melveny & Myers represented Nkarta, Inc. in the offering, and Shearman & Sterling represented the underwriters. Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural...
Evolus’ $50.0 Million Common Stock Offering
Paul Hastings LLP advised Leerink Partners and Stifel as joint bookrunning managers in the offering. Evolus, Inc. (Nasdaq: EOLS) announced the pricing of its underwritten offering...